StemX Bio
Leiden
About StemX Bio
StemX Bio is specializing in transforming diabetes drug by developing revolutionary 3D pancreatic microtissue technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $409.8K
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2025)
- Website: stemxbio.com
- Phone: +31 621 30 7999
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/stemx-bio-165735 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.